4D7B | Structure of human transthyretin in complex with Tolcapone | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Gallego, P., anna, R.O.Sant., Ventura, S., Reverter, D. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.15 | ||||||||||||
ligand | TCW | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity., Sant'Anna R, Gallego P, Robinson LZ, Pereira-Henriques A, Ferreira N, Pinheiro F, Esperante S, Pallares I, Huertas O, Rosario Almeida M, Reixach N, Insa R, Velazquez-Campoy A, Reverter D, Reig N, Ventura S, Nat Commun. 2016 Feb 23;7:10787. doi: 10.1038/ncomms10787. PMID:26902880 |
Data retrieval |
View 4D7B in 3D |
Visual 3D analysis of 4D7B |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4D7B |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |